GKWIM
SRNE

Gerber Kawasaki Wealth & Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-101
Closed – – 1222
2021
Q3 		$0 Buy
+101
New +$856 ﹤0.01% 1265

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's SRNE Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 101 shares.

Gerber Kawasaki Wealth & Investment Management first reported a position in SRNE in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 101 Sorrento Therapeutics, Inc. shares in Q4 2021.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Sorrento Therapeutics, Inc. position peaked at $0 in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.